IBH works closely with leaders from across the globe in the fields of public policy, addiction treatment, medicine, law, toxicology, among others, in both the public and private sectors and within federal offices and non-governmental organizations.
Robert L. DuPont, MD, President
For 50 years, Robert L. DuPont, MD has been a leader in drug abuse prevention and treatment. Among his many contributions to the field is his leadership as the first Director of the NIH National Institute on Drug Abuse (1973-1978) and as the second White House Drug Chief (1973-1977). From 1968 to 1970 he was Director of Community Services, for the District of Columbia Department of Corrections, heading parole and half-way house services. From 1970 to 1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration (NTA), the city-wide drug abuse treatment program that was the model for the federal government's massive commitment to drug abuse treatment in the early 1970s. Following this distinguished public career, in 1978 Dr. DuPont became the founding president of the Institute for Behavior and Health, Inc.
Dr. DuPont has written for publication over 400 professional articles and 15 books and monographs on a variety of health-related subjects. In 2018 he authored his most recent book, Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic.
His other books include The Selfish Brain: Learning from Addiction, A Bridge to Recovery: An Introduction to Twelve-Step Programs, and Getting Tough on Gateway Drugs: A Guide for the Family. In 2005, Hazelden, the nation's leading publisher of books on addiction and recovery, published three books on drug testing by Dr. DuPont: Drug Testing in Drug Abuse Treatment, Drug Testing in Schools, and Drug Testing in the Criminal Justice System.
Throughout his decades of work in addiction prevention, Dr. DuPont has served in many capacities. He is a Distinguished Fellow of the American Society of Addiction Medicine (ASAM). His activities in ASAM include chairing the forensic science committee from 1995 to 2004. He served as Co-Chair of two writing committees that produced ASAM white papers on "medical" marijuana and marijuana legalization in 2010 and 2012, respectively, and served as Chair of the writing committee that produced an ASAM white paper on drug testing in 2013. He is a Life Fellow of the American Psychiatric Association (APA) and was chairman of the Drug Dependence Section of the World Psychiatric Association (WPA) from 1974 to 1979. In 1989 he became a founding member of the Medical Review Officer Committee of ASAM.
A graduate of Emory University, Dr. DuPont received an MD degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. Dr. DuPont maintains an active practice of psychiatry specializing in addiction and the anxiety disorders and has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. Dr. DuPont's signature role throughout his career has been to focus on the public health goal of reducing the use of illegal drugs. Watch a 2016 interview with Dr. DuPont by C4 Recovery Solutions.
Caroline DuPont, MD, Vice President
In her role as Vice President of IBH, Caroline DuPont, MD focuses on the areas of addiction treatment and prevention. She maintains a private practice specializing in anxiety and addiction. She received her MD from the University of Texas Health Sciences Center, Houston and completed her training at the Johns Hopkins Hospital, Baltimore, where for years she held an appointment on the clinical faculty of psychiatry.
She is board certified by the American Board of Psychiatry and Neurology and by the American Board of Addiction Medicine. As President and Principal Investigator of DuPont Clinical Research, she directed a team of researchers that conducted studies of investigational medication for the anxiety and affective disorders. Dr. DuPont is a member of the American Psychiatric Association and the American Society of Addiction Medicine. She is the co-author of numerous publications and several books on anxiety and addiction.